These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19167839)

  • 1. Radiation-induced lymphocyte apoptosis to predict radiation therapy late toxicity in prostate cancer patients.
    Schnarr K; Boreham D; Sathya J; Julian J; Dayes IS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1424-30. PubMed ID: 19167839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients.
    Ozsahin M; Crompton NE; Gourgou S; Kramar A; Li L; Shi Y; Sozzi WJ; Zouhair A; Mirimanoff RO; Azria D
    Clin Cancer Res; 2005 Oct; 11(20):7426-33. PubMed ID: 16243816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced sequelae measured by means of lymphocyte apoptosis: importance of certain single nucleotide polymorphisms: in regard to Schnarr et al. (Int J Radiat Oncol Biol Phys 2009).
    Azria D; Ozsahin M; Rosenstein B
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1275; author reply 1275-6. PubMed ID: 19857791
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between radiation-induced apoptosis of T lymphocytes and chronic toxicity in patients with prostate cancer treated by radiation therapy: a prospective study.
    Foro P; Algara M; Lozano J; Rodriguez N; Sanz X; Torres E; Carles J; Reig A; Membrive I; Quera J; Fernandez-Velilla E; Pera O; Lacruz M; Bellosillo B
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1057-63. PubMed ID: 24661659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the ratio of CD4+ to CD8+ T-cells on radiation-induced apoptosis in human lymphocyte subpopulations.
    Wilkins RC; Kutzner BC; Truong M; McLean JR
    Int J Radiat Biol; 2002 Aug; 78(8):681-8. PubMed ID: 12194751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
    Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
    Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
    López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
    Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer.
    Koukourakis GV; Baksevanis CN; Zambatis H; Gritzapis A; Maltezos E; Simopoulos C; Koukourakis MI
    Int J Radiat Biol; 2009 Jan; 85(1):96-104. PubMed ID: 19205988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial.
    Arcangeli S; Strigari L; Soete G; De Meerleer G; Gomellini S; Fonteyne V; Storme G; Arcangeli G
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):39-45. PubMed ID: 18538488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis for prediction of radiotherapy late toxicity: lymphocyte subset sensitivity and potential effect of TP53 Arg72Pro polymorphism.
    Fuentes-Raspall MJ; Caragol I; Alonso C; Ramón y Cajal T; Fisas D; Seoane A; Carvajal N; Bonache S; Díez O; Gutiérrez-Enríquez S
    Apoptosis; 2015 Mar; 20(3):371-82. PubMed ID: 25398538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
    Pinar B; Lara PC; Lloret M; Bordón E; Núñez MI; Villalobos M; Guerrero R; Luna JD; Ruiz de Almodóvar JM
    Radiat Res; 2007 Oct; 168(4):415-22. PubMed ID: 17903032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic index as predictive marker for radiosensitivity of cervical carcinoma: evaluation of membrane fluidity, biochemical parameters and apoptosis after the first dose of fractionated radiotherapy to patients.
    Bhosle SM; Huilgol NG; Mishra KP
    Cancer Detect Prev; 2005; 29(4):369-75. PubMed ID: 16125335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual radiosensitivity does not correlate with radiation-induced apoptosis in lymphoblastoid cell lines or CD3+ lymphocytes.
    Wistop A; Keller U; Sprung CN; Grabenbauer GG; Sauer R; Distel LV
    Strahlenther Onkol; 2005 May; 181(5):326-35. PubMed ID: 15900430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of predictive assays for acute and late radiation morbidity.
    Budach W; Classen J; Belka C; Bamberg M
    Strahlenther Onkol; 1998 Nov; 174 Suppl 3():20-4. PubMed ID: 9830451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
    Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial.
    Yeoh EE; Holloway RH; Fraser RJ; Botten RJ; Di Matteo AC; Butters J; Weerasinghe S; Abeysinghe P
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1072-83. PubMed ID: 16965866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
    Dunst J; Gebhart E; Neubauer S
    Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic response of irradiated T-lymphocytes. An epidemiologic study in canine radiotherapy patients.
    Stankeová S; Crompton NE; Blattmann H; Theiler P; Emery GC; Roos M; Kaser-Hotz B
    Strahlenther Onkol; 2003 Nov; 179(11):779-86. PubMed ID: 14605749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.
    van der Laan HP; van den Bergh A; Schilstra C; Vlasman R; Meertens H; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1138-45. PubMed ID: 17931794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
    Ares C; Popowski Y; Pampallona S; Nouet P; Dipasquale G; Bieri S; Ozsoy O; Rouzaud M; Khan H; Miralbell R
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):656-63. PubMed ID: 19250768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.